Alligator Bioscience: New Clinical Study Funded - Redeye
This morning, Alligator announced the launch of a new investigator-sponsored phase II/III trial with mitazalimab in biliary tract cancer. Redeye sees the new trial as improving the investment case significantly.
ANNONS
This morning, Alligator announced the launch of a new investigator-sponsored phase II/III trial with mitazalimab in biliary tract cancer. Redeye sees the new trial as improving the investment case significantly.